Did Sheldon Whitehouse buy Regeneron Pharmaceuticals stock?

Common questions

Did Sheldon Whitehouse buy Regeneron Pharmaceuticals stock?

Yes. Sheldon Whitehouse disclosed 3 purchases and 1 sale of Regeneron Pharmaceuticals (REGN) stock between May 24, 2016 and Dec 18, 2017, in STOCK Act reports. Added together, the disclosed purchases come to $3K-$45K and the disclosed sales to $15K-$50K.

How big were Sheldon Whitehouse's Regeneron Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $15K-$50K, never an exact amount. Added together, the disclosed purchases come to $3K-$45K and the disclosed sales to $15K-$50K.

Did Sheldon Whitehouse make these Regeneron Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Sheldon Whitehouse still own Regeneron Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Sheldon Whitehouse report these trades?

The latest filing is dated Jan 10, 2018. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.